This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc., Lightship Medical Limited. Active years: 2008-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,200 
1 out of 2,532 
1 out of 10 Years Active: 2008-2021
Title: Tony James - Innovator in Glucose Sensor Technology
Introduction
Tony James is a notable inventor based in Bath, GB. He has made significant contributions to the field of glucose sensor technology, holding a total of 3 patents. His work focuses on developing innovative solutions that enhance the accuracy and selectivity of glucose detection.
Latest Patents
Among his latest patents is a glucose sensor molecule that provides a glucose receptor containing a binding site of formula (I). This invention is designed to improve the selectivity for glucose, making it a valuable advancement in glucose monitoring technology. The binding site has been found to exhibit particularly good selectivity for glucose, which is crucial for effective monitoring in diabetic patients.
Career Highlights
Throughout his career, Tony has worked with various companies, including Lightship Medical Limited. His experience in the industry has allowed him to refine his inventions and contribute to advancements in medical technology.
Collaborations
Tony has collaborated with notable individuals such as Nicholas Paul Barwell and Michael L Bell. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Tony James is a distinguished inventor whose work in glucose sensor technology has the potential to significantly impact healthcare. His innovative patents and collaborations highlight his commitment to advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile